• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

OIG Expects Tighter Control on Compounded Drugs in CMS-Approved Hospitals

Article

OIG recommends training for inspectors and amending contracts with stand-alone pharmacies to ensure improved quality and safety.

More than 2 years after drugs contaminated with a virulent fungus killed 64 patients and caused related illnesses in another 687, Medicare-approved hospital accreditors still don't properly oversee contracts hospitals have with compounding pharmacies to assure these drugs are safe, according to an Office of Inspector General report.

It recommends CMS consider requiring 55 practices to use accreditors to oversee compounded sterile preparations.

Link to the complete article on Medpage Today: http://bit.ly/1uY91MX

Related Videos
Coral Omene, MD, PhD, sitting for a vieo interview
David Awad, PharmD, BCOP
Screenshot of Coral Omene, MD, PhD
Constance Blunt, MD, medical oncologist, Mary Bird Perkins Cancer Center
Ali Khawar
Eileen Peng, PharmD, sitting for a video interview
Ali Khawar
Eileen Peng, PharmD, sitting for a video interview
Emma Achola-Kothari, PhD
Related Content
© 2025 MJH Life Sciences
AJMC®
All rights reserved.